These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8883266)

  • 1. Erythromelalgia in essential thrombocythemia is characterized by platelet activation and endothelial cell damage but not by thrombin generation.
    van Genderen PJ; Lucas IS; van Strik R; Vuzevski VD; Prins FJ; van Vliet HH; Michiels JJ
    Thromb Haemost; 1996 Sep; 76(3):333-8. PubMed ID: 8883266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
    van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
    Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
    Michiels JJ
    Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF.
    Bellucci S; Ignatova E; Jaillet N; Boffa MC
    Thromb Haemost; 1993 Nov; 70(5):736-42. PubMed ID: 8128427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin.
    Koudstaal PJ; Koudstaal A
    Semin Thromb Hemost; 1997; 23(4):365-70. PubMed ID: 9263353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin in essential thrombocythemia: status quo and quo vadis.
    Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Responsive Thrombotic Complications in Thrombocythemia Vera. A Novel Platelet-Mediated Arterial Thrombophilia.
    Michiels JJ
    Turk J Haematol; 2002 Jun; 19(2):225-33. PubMed ID: 27264763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
    Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
    Yasuba H; Chihara J; Kino T; Satake N; Oshima S
    J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
    Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
    Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin formation and platelet activation at the site of vascular injury in patients with coronary artery disease treated with clopidogrel combined with aspirin.
    Undas A; Stepień E; Branicka A; Wołkow P; Zmudka K; Tracz W
    Kardiol Pol; 2009 Jun; 67(6):591-8. PubMed ID: 19618315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
    van Genderen PJ; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
    Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.